ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas.

Maite Verreault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.